Page 23 - Delaware 222 - 2025

BIOPHARMACEUTICAL BUSINESS ORGANIZATION
Kris Vaddi
Prelude Therapeutics
Kris Vaddi spent 14 years at Incyte
where he helped develop one of its
most important drugs, Jakafi . After
two decades in the biopharmaceutical
industry though, he wanted to return
to the grassroots innovation of a
startup, and left to found Prelude
Th erapeutics in 2016. Th e company
has drawn increasing international
attention for its work on small
molecule inhibitors, a developing
therapy that is more targeted in
approach with fewer side eff ects
than traditional cancer therapies like
chemotherapy or radiation. Prelude is
working on treatments for blood, brain,
and lymph node cancers. Th e promise
of Prelude’s work drove it to become
the newest publicly traded company to
IPO from Delaware, raising hundreds
of millions of dollars from investors
since 2020.
Yvonne Deadwyler
New Castle County
Chamber of Commerce
Since she joined the New Castle County
Chamber of Commerce in 2019 in
member relations, Yvonne Deadwyler
has worked to support and accelerate
business growth in Delaware’s largest
county. When she was promoted
to president in 2024, she made it
her goal to support, promote and
advocate for the New Castle County
business community, as well as the
Delaware business community at-large.
Th e chamber supports economic
development and adds value to new
and existing plans to contribute to
the economic vitality of our county,
which has an overall impact on the
state. Under her leadership, she has
hosted marquee events like the annual
economic forecast and the women’s
leadership conference, while starting
EDx Talks to drive conversation among
business leaders.
ALMA MATERS:
BOARDS:
Q&A:
ALMA MATER:
BOARDS:
Q&A:
Congratulations
HERVÉ HOPPENOT
on your Delaware Business Times
Delaware 222 recognition.
DelawareBusinessTimes.com | DELAWARE 222 21
DelawareBusinessTimes.com | DELAWARE 222 21
DelawareBusinessTimes.com | DELAWARE 222 21